Crescent Biopharma (CBIO) Return on Capital Employed Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -494.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -649.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 4,853.00 |
| 10 | Crescent Biopharma | 569.36 Mn | 380.20 Mn | - | 208.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 208.00 |
| Dec 31, 2025 | 571.00 |
| Sep 30, 2025 | 4,134.00 |
| Jun 30, 2025 | 1,283.00 |
| Mar 31, 2025 | -15,918.00 |
| Dec 31, 2024 | -18,636.00 |
| Sep 30, 2024 | -15,629.00 |
| Jun 30, 2024 | -11,586.00 |
| Mar 31, 2024 | -6,994.00 |
| Dec 31, 2023 | -5,420.00 |
| Sep 30, 2023 | -4,338.00 |
| Jun 30, 2023 | -3,245.00 |
| Mar 31, 2023 | -4,626.00 |
| Dec 31, 2022 | -6,773.00 |
| Sep 30, 2022 | -6,808.00 |
| Jun 30, 2022 | -6,595.00 |
| Mar 31, 2022 | -5,776.00 |
| Dec 31, 2021 | -4,652.00 |
| Sep 30, 2021 | -3,714.00 |
| Jun 30, 2021 | -3,002.00 |
| Mar 31, 2021 | -2,326.00 |
| Dec 31, 2020 | -863.00 |
| Sep 30, 2020 | -627.00 |
| Jun 30, 2020 | 958.00 |
| Mar 31, 2020 | 5,646.00 |
| Dec 31, 2019 | 4,451.00 |
| Sep 30, 2019 | 3,513.00 |
| Jun 30, 2019 | 4,364.00 |
| Mar 31, 2019 | 686.00 |
| Dec 31, 2018 | 431.00 |
| Sep 30, 2018 | 101.00 |
| Jun 30, 2018 | 442.00 |
| Mar 31, 2018 | 571.00 |
| Dec 31, 2017 | -889.00 |
| Sep 30, 2017 | -1,657.00 |
| Jun 30, 2017 | -3,610.00 |
| Mar 31, 2017 | -3,596.00 |